SPONDYLOARTHRITIS

This study tested a daily pill called upadacitinib in 734 adults with a form of arthritis that causes back pain and stiffness (axial spondyloarthritis). The goal was to see if the drug reduces symptoms better than a placebo. Participants took the drug or a placebo for 14 weeks, a…

This study tested whether using connected fitness devices (like activity trackers) can help people with spondyloarthritis become more physically active and reduce disease flare-ups. 108 adults with stable spondyloarthritis participated. The goal was to see if technology encourage…

This study checked if patients with rheumatoid arthritis, spondyloarthritis, Crohn's disease, or uveitis could safely switch from the original drug Remicade to its lower-cost biosimilar Inflectra. Researchers followed 262 patients at one hospital to see how many stayed on the bio…

This study tested whether people with rheumatoid arthritis, psoriatic arthritis, or spine arthritis could safely switch from receiving infliximab through an IV infusion at a clinic to giving themselves a simple shot under the skin at home. 22 adults who were already stable on IV …

This study looked at whether shiatsu, a Japanese finger-pressure therapy, can reduce fatigue in people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine). 72 adults with the condition received shiatsu sessions, and researchers measured changes in …

This study looked at whether five easy physiotherapy exercises could help older adults (ages 65-95) with spine arthritis improve their balance and reaction speed. Sixty people were split into two groups: one did a three-week exercise program, the other did not. Results showed tha…

This study looked at 70 people with spondyloarthritis (a type of inflammatory arthritis affecting the spine and joints) to find immune markers that might predict how the disease will progress and how well treatments work. Participants gave blood samples and had their disease acti…

This study aimed to find blood markers that can predict whether the drug adalimumab will successfully treat ankylosing spondylitis after 6 months. Researchers analyzed blood samples from 50 adults starting adalimumab for the first time. The goal was to create an algorithm to help…